|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Capivasertib>> Market Analysis Reports |
Market Analysis Reports of Capivasertib |
|
RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) - Pipeline Review, H2 2018 RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 2.7.11.1) - Pipeline Review, H2 2018 SUMMARY According to the recently published report 'RAC Alpha SerineThreonine ... RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) - Pipeline Review, H2 2018 RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) - Pipeline Review, H2 2018 SUMMARY RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC ... RAC Alpha SerineThreonine Protein Kinase - Pipeline Review, H2 2019 RAC Alpha SerineThreonine Protein Kinase - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'RAC Alpha SerineThreonine Protein Kinase - Pipeline Review, H2 2019'; RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or ... RAC Beta SerineThreonine Protein Kinase - Pipeline Review, H2 2019 RAC Beta SerineThreonine Protein Kinase - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'RAC Beta SerineThreonine Protein Kinase - Pipeline Review, H2 2019'; RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or ... RAC Gamma SerineThreonine Protein Kinase - Pipeline Review, H2 2019 RAC Gamma SerineThreonine Protein Kinase - Pipeline Review, H2 2019 SUMMARY RAC Gamma Serine/Threonine Protein Kinase (Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1) pipeline Target constitutes close to 9 ... RAC Alpha Serine/Threonine Protein Kinase - Pipeline Review, H1 2020 RAC Alpha Serine/Threonine Protein Kinase - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'RAC Alpha SerineThreonine Protein Kinase - Pipeline Review, H1 2020'; RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or ... RAC Beta Serine/Threonine Protein Kinase - Pipeline Review, H1 2020 RAC Beta Serine/Threonine Protein Kinase - Pipeline Review, H1 2020 SUMMARY RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) pipeline Target constitutes close to 9 molecules. The ... Prostate Cancer – Pipeline Insight, 2020 ... Myovant Taiho Oncology Key Products Capivasertib PLX3397 ABX-EGF ODM-201 ... Proto oncogene protein c-akt inhibitors - Pipeline Insight, 2022 ... Ipatasertib Curcumin liposomal Paxalisib Tucidinostat Capivasertib Miransertib Afuresertib Enzastaurin CU 05 API-2 Pravitinib ... Prostate Cancer Therapeutics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Hormonal Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, and Others), End User (Hospitals, Specialty Clinics, and Others), and Geography ... Clinical Trial Phase 1 AstraZeneca capivasertib Clinical Phase II capivasertib + abiraterone CAPItello-281 Clinical ... Meningioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major meningioma markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 9.79% during 2024-2034. The meningioma market has been ... Invasive Ductal Carcinoma Treatment Market Size, Share & Trends Analysis Report By Therapy (Targeted Therapy, Hormonal Therapy), By Type (Hormone Receptor, HER2+), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 ... instance, in March 2024, AstraZeneca’s Truqap (capivasertib) received approval in Japan for use ... Docetaxel Market Size, Share & Trends Analysis Report By Indication (Breast Cancer, Non-Small Cell Lung Cancer, Hormone Refractory Prostate Cancer, Gastric Adenocarcinoma), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 ... (Daiichi Sankyo), daraxonrasib (Revolution Medicines), capivasertib (AstraZeneca), and others target NSCLC ... Metastatic Breast Cancer Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type ... (40% of HR+), alpelisib's SOLAR-1 validates with fulvestrant; capivasertib's CAPItello-291 combo signals AKT ... in 2024, patents varying regionally; Truqap (capivasertib) contributed USD 400-500 million ... |